PEN – Penumbra, Inc.

PEN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.42

Margin Of Safety %

-18

Put/Call OI Ratio

0.99

EPS Next Q Diff

-0.01

EPS Last/This Y

0.48

EPS This/Next Y

1.37

Price

335.2

Target Price

369.23

Analyst Recom

2.72

Performance Q

6.08

Upside

-52.8%

Beta

0.82

Ticker: PEN

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	PEN	342.17	0.95	1.93	5671
2026-03-04	PEN	339.61	1.02	0.56	6870
2026-03-05	PEN	340.5	1.00	1.66	7082
2026-03-09	PEN	339.72	0.99	1.29	7106
2026-03-10	PEN	336.75	1.00	1.60	7132
2026-03-11	PEN	335.96	1.01	3.25	7224
2026-03-12	PEN	335	1.01	0.43	7235
2026-03-17	PEN	338	1.00	0.85	7334
2026-03-18	PEN	338.29	1.00	999.99	7342
2026-03-19	PEN	337.39	1.01	0.80	7364
2026-03-20	PEN	336.12	0.99	0.88	7555
2026-03-23	PEN	335.5	0.98	0.74	7450
2026-03-24	PEN	334.23	0.96	1.38	7586
2026-03-25	PEN	336.23	0.97	12.67	7585
2026-03-26	PEN	336.52	0.99	999.99	7643
2026-03-27	PEN	335.11	0.99	1.48	7643
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-02-27	PEN	344.45	14.7	127.6	3.77
2026-03-02	PEN	342.30	29.4	57.9	5.01
2026-03-03	PEN	340.34	29.4	58.0	5.01
2026-03-04	PEN	339.58	29.4	59.0	5.01
2026-03-05	PEN	340.68	24.8	60.2	5.01
2026-03-06	PEN	338.66	24.8	58.0	5.01
2026-03-09	PEN	339.64	28.0	40.9	5.04
2026-03-10	PEN	336.74	29.4	38.0	5.04
2026-03-11	PEN	335.89	29.4	39.5	5.04
2026-03-12	PEN	334.90	29.4	39.2	5.05
2026-03-13	PEN	336.11	29.4	41.0	5.05
2026-03-17	PEN	338.01	29.4	41.5	5.05
2026-03-18	PEN	338.25	29.4	40.3	5.05
2026-03-19	PEN	337.38	29.4	37.5	5.05
2026-03-20	PEN	336.11	29.4	37.2	5.05
2026-03-23	PEN	335.61	29.4	38.0	5.05
2026-03-24	PEN	334.17	29.4	37.1	5.05
2026-03-25	PEN	336.26	29.4	39.7	5.05
2026-03-26	PEN	336.49	29.4	38.3	5.05
2026-03-27	PEN	335.20	29.4	37.3	5.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-02-27	PEN	-4.04	-6.97	4.90
2026-03-02	PEN	-4.04	-6.05	4.90
2026-03-03	PEN	-4.04	-6.05	4.90
2026-03-04	PEN	-4.04	-6.05	4.90
2026-03-05	PEN	-2.96	-6.05	4.90
2026-03-06	PEN	-2.96	-6.05	4.90
2026-03-09	PEN	-2.96	-5.95	4.90
2026-03-10	PEN	-2.96	-5.95	4.90
2026-03-11	PEN	-2.96	-5.95	4.91
2026-03-12	PEN	-2.96	-5.95	4.91
2026-03-13	PEN	-2.96	-5.95	4.91
2026-03-17	PEN	-2.96	-5.97	4.91
2026-03-18	PEN	-2.96	-5.97	4.91
2026-03-19	PEN	-2.96	-5.97	4.91
2026-03-20	PEN	-2.96	-5.97	4.91
2026-03-23	PEN	-2.96	-5.97	4.91
2026-03-24	PEN	-2.96	-5.97	4.91
2026-03-25	PEN	-2.96	-5.97	5.42
2026-03-26	PEN	-2.96	-5.97	5.42
2026-03-27	PEN	-2.96	-5.97	5.42
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.2

Avg. EPS Est. Current Quarter

1.07

Avg. EPS Est. Next Quarter

1.19

Insider Transactions

-2.96

Institutional Transactions

-5.97

Beta

0.82

Average Sales Estimate Current Quarter

372

Average Sales Estimate Next Quarter

390

Fair Value

276.22

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

7.5

Max Drawdown 5-Year %

-62.6

Target Price

369.23

P/E

74.07

Forward P/E

52.94

PEG

2.07

P/S

9.37

P/B

9.21

P/Free Cash Flow

75.17

EPS

4.52

Average EPS Est. Cur. Y

5.05

EPS Next Y. (Est.)

6.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

12.66

Relative Volume

0.56

Return on Equity vs Sector %

-14.9

Return on Equity vs Industry %

0.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

37.3

◆ PEN Healthcare

$335.06

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

24/25

Volume

11/15

Valuation

10/20

TP/AR

2/10

Options

3/10

RSI

43.3

Range 1M

13.4%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

21/30

Estimates

8/20

Inst/Vol

2/15

Options

4/10

EPS Yr

30.4%

EPS NY

26.4%

52W%

80.7%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -19.7% upside

Quality

18/30

Valuation

1/30

Growth

21/25

Stability

7/10

LT Trend

0/5

Upside

-19.7%

Quality

MoS

-18%

Penumbra, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 4700

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

PEN

Latest News

—

Caricamento notizie per PEN…

stock quote shares PEN – Penumbra, Inc. Stock Price stock today

news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PEN – Penumbra, Inc. yahoo finance google finance

stock history PEN – Penumbra, Inc. invest stock market

stock prices PEN premarket after hours

ticker PEN fair value insiders trading

PEN – Penumbra, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y